Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02498795 |
|
Recruitment Status :
Completed
First Posted : July 15, 2015
Last Update Posted : December 4, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tendinopathy | Other: Group of Dry Needling Other: Group of Electrolysis Other: Control Group | Not Applicable |
Experimental study randomized with double blind, whose purpose is to compare three protocols in those who apply different protocols of physical therapy to themselves in three groups of intervention with patients with chronic patellar tendinopathy.
There take part in this study young women of both sexes, of Zaragoza and of different sports clubs of entity 18 and 40 years, that they realize of habitual form (minimum 3 times a week) a sport. All of them present chronic patellar tendinopathy.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Triple (Participant, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Comparative Research Among 3 Action Protocol in Other to Approach Chronic Patellar Tendinopathy |
| Actual Study Start Date : | January 1, 2019 |
| Actual Primary Completion Date : | December 31, 2019 |
| Actual Study Completion Date : | May 2, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Group of Dry Needling
They will receive a treatment of dry needling with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile. The needle will get in the relevant zone of treatment. The punction will be realized using the technique of entry - Hong's rapid exit. Three punction will realize in the disabled zone of 3 seconds of duration. |
Other: Group of Dry Needling
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day. |
|
Active Comparator: Group of electrolysis
They will receive a treatment of Intratissue Percutaneous Electrolysis with ultrasound scan together with a treatment in which they will realize eccentric exercise's program that the patient will have to realize in his domicile. The needle will get in the relevant zone of treatment. An intensity of 3 milliampere will be in use, during 3 seconds and one will repeat 3 times. |
Other: Group of Electrolysis
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day. |
|
Placebo Comparator: Control Group
They will receive a treatment of punction placebo with ultrasound scan together with a treatment in the one that will realize eccentric exercise's program that the patient will have to realize in his domicile.
|
Other: Control Group
Every group will receive a total of 4 treatment distributed throughout 8 weeks of treatment. The program of eccentric exercises that will have to realize it in his domicile every day. |
- Change from baseline in functionality at 8 weeks as measured by Visa-p [ Time Frame: 8 weeks ]This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.
- Pain, as measured by Visual Analog Scale [ Time Frame: 0, 8 and 20 weeks ]Participants will be explained that a score of 0 indicates the absence of pain whereas a score of 10 represents the maximum tolerable pain
- Quality of life by SF-36 [ Time Frame: 0, 8 and 20 weeks ]Health Survey
- Thickness of the tendon, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]Tendon structure
- Height of the jump [ Time Frame: 0, 8 and 20 weeks ]Jump test with a force platform
- Concentric force of the low members [ Time Frame: 0, 8 and 20 weeks ]Jump test with a force platform
- Speed of the jump [ Time Frame: 0, 8 and 20 weeks ]Jump test with a force platform
- Hypervascularity, as measured by ultrasound scan [ Time Frame: 0, 8 and 20 weeks ]Tendon structure
- Functionality, as measured by Visa-p [ Time Frame: 0 and 20 weeks ]This scale consists of eight questions, the first six questions of which employ an analogical visual scale in order to assign a score of 0 to 10, where 10 represents the optimum state, for the purpose of quantifying pain and function in different activities, whereas the last two questions assess the level of functionality and ability to perform physical activity.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age understood between 18 and 40 years.
- To practise any sport of habitual form.
- Patients diagnosed of chronic patellar tendinopathy with a minimum of 3 months of evolution and with stable symptomatology.
- Pain to the palpation of the tendon in the low pole of the knee and during the training or competition.
- Punctuation of the questionnaire VISA-P under 80.
Exclusion Criteria:
- Patient had an operation on the knee affected in the last 6 months.
- Infiltrations in the knee affected in the last 3 months.
- Patient who has received pharmacological treatment or physical therapy in the last 48 hours.
- Pathology with less than 3 months of evolution.
- To present bilateral chronic tendinopathy.
- Punctuation of the questionnaire major or equal Visa - p of 80.
- Inability to apply someone of the techniques of treatment or valuation for absolute or relative contraindication.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02498795
| Spain | |
| Universidad San Jorge | |
| Villanueva de Gállego, Zaragoza, Spain, 50830 | |
| Study Director: | Eva Gómez-Trullén, PhD | Universidad de Zaragoza | |
| Study Director: | Pablo Herrero, PhD | Universidad San Jorge |
| Responsible Party: | Maria Pilar López Royo, Graduate, Universidad de Zaragoza |
| ClinicalTrials.gov Identifier: | NCT02498795 |
| Other Study ID Numbers: |
P115/0017 |
| First Posted: | July 15, 2015 Key Record Dates |
| Last Update Posted: | December 4, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Intratissue Percutaneous Electrolysis Dry needling Eccentric exercise Patella |
|
Tendinopathy Muscular Diseases Musculoskeletal Diseases Tendon Injuries Wounds and Injuries |